Passage 2
Donegal is located in the windswept wilderness. It might seem an odd place to find one of Europe’s most dynamic companies. But a small assembly unit making a muscular stimulation product for leisure and healthcare is blazing a trail. BMR
Passage 2
Donegal is located in the windswept wilderness. It might seem an odd place to find one of Europe’s most dynamic companies. But a small assembly unit making a muscular stimulation product for leisure and healthcare is blazing a trail. BMR Teoranta—the company title in Irish—has quietly established a market for itself, making products for muscular therapy and body toning using the brand name Slendertone which it bought in 1989.
Mr. Kevin McDonnell, the chairman, chief executive and owner of 95 per cent of the company, is a little vague about the source of his success. Part of it, he says, must be the strong work ethic in the area. He points out that half his employees are from Galswegian families with their Scottish attitudes of thrift and industry. Mr. McDonnell bought the company for $300,000 and BMR sales are now growing at around 50-60 per cent a year.
The medical products business, where growth is less dramatic, but margins are attractive, is seen as the source of the company’s future earnings. In the US alone, the market for muscular stimulation products has jumped from $88m to more than $200m this year.
Many BMR products are not available over the counter but through catalogues. The company is looking at special advertising on video shopping channels. In the US companies like BMR are prohibited from selling medical products over the counter. In Europe this situation is slightly different. BMR, for example, is starting to sell its consumer range in Carrefour superstores in France and its range is available in pharmacies. However, under a European Union ruling similar to US laws, companies that sell such products will have to reequip their factories to meet new health standards. “I know it sounds a bit smart, but our products have always been seen as industry standard,” says Mr. Kevin McDonnell.
The company spends £1,000,000 a year on research and development, quite a large sum for a company of its size.
50.It can be inferred that US laws for selling health products are stricter than the corresponding laws in Europe.
A、True
B、False
【正确答案】:A
【名师解析】:根据文章内容,可以推断美国对销售健康产品的规定比欧洲更为严格。文章中提到,在欧洲,BMR公司开始在法国的家乐福超市销售其消费类产品,并且其产品在药店也有销售。然而,根据一项类似于美国法律的欧盟裁决,销售这类产品的公司将不得不重新装备他们的工厂以满足新的健康标准。这表明美国对医疗产品的柜台销售有禁令,而欧洲则允许在特定条件下销售,但也需要满足一定的健康标准。因此,选项A "True" 是正确的。
Top